Skip to main content

Filter content

October 21, 2020
Students diagnosed with depression undergo a drop in educational performance around ages 15 and 16 years, and boys and students from deprived backgrounds may be especially vulnerable, a study shows.
October 21, 2020
The Foundation for Opioid Response Efforts (FORE) has announced it will provide more than $634,000 in grants to 10 organizations to help at-risk populations that are struggling with increases in opioid use and overdoses during the COVID-19 pandemic. This is the second wave of grants distributed by…
Q&A
October 21, 2020
Laura J. Fochtmann, MD, MBI, shares insights on a new set of evidence-based practice guidelines for the treatment of patients with schizophrenia, which she helped write.
October 21, 2020
Purdue Pharma, maker of the prescription pain medication OxyContin, will plead guilty to three federal charges, including conspiracy to defraud the United States and violating anti-kickback laws, as part of an $8 billion settlement, according to an Associated Press report. Among the terms of the…
NEUROPSYCHIATRY TRACK
October 21, 2020
In this video, Joohi Jimenez‑Shahed, MD, explains a 3-year, open-label study which evaluated the long-term efficacy and safety of deutetrabenazine, a treatment for the movement disorder tardive dyskinesia. 
October 21, 2020
After 25 years as CEO of Caron Treatment Centers, Doug Tieman announced recently that he plans to retire in June 2021. As he sketches out his next chapter, Tieman joins the BHE Podcast to share thoughts on how his own recovery has shaped his leadership style and management at Caron, why not-for-…
October 20, 2020
Researchers have discovered a brain abnormality in people with obsessive-compulsive disorder (OCD) that may help predict which patients are most likely to respond to treatment with cognitive behavioral therapy (CBT).
October 20, 2020
In this video, Joseph F. Goldberg, MD, explains the conditions under which lithium may be an effective treatment for patients with bipolar disorder.
October 20, 2020
NewVista Healthcare, an Ohio-based operator of behavioral health hospitals, substance use disorder treatment facilities and other behavioral health providers, announced that it is expanding into the Greater Cleveland area with two SUD treatment centers. Construction on a 140-bed facility in Euclid…
October 20, 2020
Outpatient opioid addiction treatment provider Behavioral Health Group is continuing its expansion with the acquisition of two programs in Alabama, Huntsville Recovery and Stevenson Recovery. The deal for the two Alabama properties follow BHG’s recent move into Rhode Island with its purchase of the…
Back to Top